Home > Publications >Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH >

<<Previous Next>>

Post Date:Jul-29-21

Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH

AcceGenAuthor: AcceGen R&D Team

Date Published: 29-Jul-21

Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH

  • Authors: Jinrui Dong, Sivakumar Viswanathan, Eleonora Adami, Brijesh K. Singh, Sonia P. Chothani, Benjamin Ng, Wei Wen Lim, Jin Zhou, Madhulika Tripathi, Nicole S. J. Ko, Shamini G. Shekeran, Jessie Tan, Sze Yun Lim, Mao Wang, Pei Min Lio, Paul M. Yen, Sebastian Schafer, Stuart A. Cook & Anissa A. Widjaja
  • Journal: Nature Communications
  • DOI: 10.1038/s41467-020-20303-z
  • Cited AcceGen Product/Service: Mouse Hepatocytes

<<Previous Next>>

AcceGen Scroll Top Button
Copy link
Powered by Social Snap